The HCMV chemokine receptor US28 is a potential target in vascular disease.

Research output: Contribution to journalReview articlepeer-review

24 Scopus citations


The human cytomegalovirus (HCMV) has been implicated in the acceleration of vascular disease for some time. The development of vascular disease involves a chronic inflammatory process with many contributing factors, and of these, chemokines and their receptors have recently been identified as key mediators. Interestingly, HCMV encodes four potential chemokine receptors (US27, US28, UL33 and UL78). Of these virally-encoded chemokine receptors, US28 has been the most widely characterized. US28 binds many of the CC-chemokines, and this class of chemokines contributes to the development of vascular disease. Importantly, HCMV infection mediates in vitro SMC migration, which is dependent upon expression of US28 and CC-chemokine binding. US28 and the US28 functional homologues that are capable of inducing the migration of SMC represent potential targets in the treatment of CMV-accelerated vascular disease such as atherosclerosis, restenosis, and transplant vascular sclerosis.

Original languageEnglish (US)
Pages (from-to)151-158
Number of pages8
JournalCurrent drug targets. Infectious disorders
Issue number2
StatePublished - Aug 2001

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Microbiology (medical)


Dive into the research topics of 'The HCMV chemokine receptor US28 is a potential target in vascular disease.'. Together they form a unique fingerprint.

Cite this